CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
APAC
CANADA

About Us

Conference

Partner With Us

  • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    BioTech
    Cell and Gene Therapy
    Clinical Trial
    Drug Discovery and Development
    Life Science AI
    Regenerative Medicine
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    Blood Bank
    CDMO
    Clinical Laboratory
    CRO
    Life Science Testing
    Skin Care
    Supplements
  • Business Services
    Life Science Consulting
    Life Science Facility Service
    Life Science Financial Services
    Life Science Marketing
    Life Science Recruitment Firms
    Pharma Wholesale and Distribution
    Pharmacy Management
    Regulatory and Compliance
    Regulatory Services
  • Leadership Perspectives
  • Innovation Insights
  • Research
  • News
  • Magazines
  • CXO Awards
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Regenesiss has been recognized by Life Sciences Review Magazine as the exclusive recipient of “Top 5 Cell and Gene Therapy Companies In UK - 2024,” based on our proprietary methodology, reflecting its position in the industry. This profile has been developed by the Life Sciences Review research and editorial team based on insights from an interview with , .

Regenesiss
Quest for Musculoskeletal Wellness

Regenesiss

Dr. Fahad Attar, Consultant Orthopaedic Surgeon and CEO, RegenesissDr. Fahad Attar, Consultant Orthopaedic Surgeon and CEO
According to the World Health Organization (WHO), osteoarthritis is one of the leading causes of disability worldwide, affecting millions of individuals.

Initial management of this joint ailment often involves physical therapy and pain medications, whereas the progression to advanced stages may necessitate joint replacement surgeries. However, a notable treatment chasm exists for those in the moderate phase of osteoarthritis—individuals who find conservative treatments insufficient yet are not in immediate need of surgical intervention.

This gap is where Regenesiss seeks to make a difference.

Specialising in orthobiological therapies, the company aims to tap into the body’s natural healing abilities. This approach focuses on stimulating tissue repair, cartilage rebuilding, reducing inflammation and enhancing joint function, offering an alternative to the risks and recovery associated with invasive surgeries.

What sets Regenesiss apart is its holistic patient care strategy. The clinic has a multidisciplinary team of highly skilled professionals, including orthopaedic surgeons, physical therapists, nutritionists, pharmacologists, pain consultants and rheumatologists. They work in unison to offer a comprehensive suite of musculoskeletal consultations and services, ensuring that each patient receives well-rounded care tailored to their needs.

Dr. Fahad Attar, consultant orthopaedic surgeon and CEO of Regenesiss, highlights the critical role of patient education in the healing journey. He states, “Education is a cornerstone of our healing approach. We extend learning opportunities to both professionals and patients through seminars and Q&A sessions. This open forum encourages discussion and ensures patients are well-informed about their treatment options.”

Regenesiss adopts a straightforward yet effective approach—conducting a comprehensive assessment of each patient’s condition to devise tailored treatment plans, moving away from the generic one-size-fits-all methodology. This process begins with an in-depth patient history and a thorough diagnostic evaluation to uncover any underlying issues. What follows is a bespoke treatment process that consists of the right mix from a diverse array of advanced biological treatment options. Among these are treatments like platelet-rich plasma (PRP) and platelet-derived growth factor (PDGF) injections, which leverage the body’s own regenerative capabilities to encourage tissue healing and repair.

For the more intricate cases, Regenesiss employs advanced therapies like bone marrow aspirate concentrate (BMAC) and nanofat mesenchymal cell treatments designed to promote cellular regeneration. These foundational treatments are complemented by additional options, such as Arthrosamid injections, targeted at individuals with moderate to advanced osteoarthritis, offering them sustained relief. In addition to these foundational treatments, the clinic provides hyaluronic acid injections to lubricate joints and enhance mobility, alongside Goldic injection therapy for those battling persistent tendinitis. This extensive array of orthobiologic therapies opens up new avenues for individuals seeking alternatives to surgical interventions or long-term medication reliance.

The therapeutic approach of Regenesiss further proves to be a boon for people suffering from sports injuries. By leveraging orthobiologic therapies, Regenesiss not only enhances the quality of life and athletic performance of these individuals but ensures shorter recovery periods, allowing them to return to their active lifestyles more swiftly.

A compelling testament to the efficacy of orthobiologics is the story of a professional hockey player who represented her country on the international stage, including the Olympics. She approached the clinic with debilitating hip pain that hindered her ability to train and compete. Diagnostic procedures uncovered a cartilage tear in her hip, which was addressed with Platelet-Rich Plasma (PRP) injection therapies and supplemented by nutritional guidance. The response to this tailored treatment was profound; within weeks, she made a comeback, competing again at the highest levels. Further supported by follow-up PRP injections, she achieved full recovery, restoring her to elite functionality in playing for the UK.

We empower individuals to reclaim their vitality and mobility, offering a profound lifeline to those grappling with the debilitating challenges of musculoskeletal disorders, sports injuries and osteoarthritis

While ensuring the best possible outcome for each patient, Regenesiss carefully selects procedures to implement through active participation in clinical trials, collaboration with renowned research institutions and guidance from a globally sourced advisory board of seasoned consultants. The international ensemble ensures the clinic’s practices are at par with global advancements, prioritising safety and efficacy. By adhering to stringent regulatory standards and evidence-based practices, Regenesiss guarantees that all treatments are thoroughly researched, scientifically backed and sourced with a keen emphasis on quality, safety and proven outcomes.

Regenesiss’ dedication to providing the best possible care for its patients has garnered widespread recognition. A highlight of this acclaim came when Dr. Attar was bestowed with the esteemed ‘Orthopaedic Surgeon of the Year Global 2023’ award by the FORTTUNA Global Excellence Awards 2023 in Dubai, a clear acknowledgement of the clinic’s exceptional commitment to patient care and its contributions to the advancement of regenerative orthopaedics.

With a focus on accessibility, Regenesiss operates its flagship clinic in Manchester, a satellite clinic in London and facilities in Scotland and the Midlands. This extensive network enables the company to cater to a wide geographical area. Beyond its physical locations, Regenesiss embraces technology through virtual consultations, allowing patients across the UK to easily access its pioneering regenerative therapies.

Eyeing a future beyond national borders, Regenesiss is planning to expand its operations internationally, with new facilities slated for Dubai, Saudi Arabia (KSA), Nigeria, Turkey and Egypt within the next three years. This strategic expansion is designed to enhance the accessibility of the clinic’s groundbreaking treatments on a global scale, aiming to make a significant impact in transforming orthopaedic wellness worldwide.

Regenesiss Viewpoints

Welcome to Regenesiss: Leading the Charge in Regenerative Medicine

Dr. Fahad G. Attar Consultant Orthopaedic Surgeon and CEO & Founder
At Regenesiss, our mission is to lead the future of regenerative orthopaedics by offering groundbreaking technologies, personalized care, and innovative solutions that enhance patient outcomes and provide exceptional value to our collaborative partners. We are committed to pushing the boundaries of medical science, ensuring that our treatments are state-of-the-art, safe, and tailored to meet the unique needs of each patient.
Welcome to Regenesiss: Leading the Charge in Regenerative Medicine
Top 5 Cell and Gene Therapy Companies In UK - 2024
Current Issue

Company : Regenesiss

Management
Dr. Fahad Attar, Consultant Orthopaedic Surgeon and CEO

Thank you for Subscribing to Life Science Review Weekly Brief

Life Sciences Review
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/regenesiss